Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.

Roehmel, Jobst; Specht, Philip; Staab, Doris; Schwarz, Carsten; Salama, Abdulgabar; Mayer, Beate

Roehmel, Jobst; Specht, Philip; Staab, Doris; Schwarz, Carsten; Salama, Abdulgabar; Mayer, Beate.

Afiliação

Roehmel J; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine - Division of Cystic Fibrosis, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Specht P; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine - Division of Cystic Fibrosis, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Staab D; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine - Division of Cystic Fibrosis, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Schwarz C; Department of Pediatric Pneumology, Immunology and Intensive Care Medicine - Division of Cystic Fibrosis, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Salama A; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Mayer B; Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Transfusion ; 59(12): 3746-3754, 2019 12.

Article em En | MEDLINE | ID: mdl-31724753

Assuntos

Anemia Hemolítica/induzido quimicamente; Fibrose Cística/metabolismo; Piperacilina/toxicidade; Adulto; Anemia Hemolítica/metabolismo; Antibacterianos/uso terapêutico; Feminino; Humanos; Pessoa de Meia-Idade; Estudos Observacionais como Assunto; Estudos Prospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperacilina / Fibrose Cística / Anemia Hemolítica Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google